Innovation today, healthier tomorrows

What's New

More

RSS

2017.02.24
Corporate
PDF/29KB
Sumitomo Dainippon Pharma announces Changes of Representative Directors and Executive Officers
2017.01.31
Finances
 
Posted Conference Call for Third Quarter Financial Results for FY2016 [Webcast]
2017.01.28
Products
PDF/295KB
Sunovion’s Latuda (lurasidone HCl) Receives FDA Approval to Treat Adolescents with Schizophrenia
2017.01.27
Finances
PDF/1524KB
Presentation Material (Third Quarter Financial Results for FY2016)
2017.01.27
Finances
PDF/558KB
Supplementary Financial Data for the Third Quarter of the Year Ending March 31, 2017
2017.01.27
Finances
PDF/324KB
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2017 [Japanese GAAP] (Unaudited)